Aim ImmunoTech CEO Equels buys $5,093 of common stock
In
Investing.comBy Investing.com10/23/2026, 5:01:01 PM
EXECUTIVE SUMMARY
Aim ImmunoTech CEO Equels buys $5,093 of common stock....
Key Takeaways
- Aim ImmunoTech CEO Equels buys $5,093 of common stock.
Read Complete Original Article
Published originally on Investing.com
Related News
finance13 minutes ago
Macy’s declares quarterly dividend of 19.15 cents per share
Macy’s declares quarterly dividend of 19.15 cents per share....
finance21 minutes ago
Raymond James reiterates Alnylam stock Strong Buy on positive trial data
Raymond James reiterates Alnylam stock Strong Buy on positive trial data....
finance26 minutes ago
Oil Price Nears Yearly High: Is a Stock and Crypto Crash Coming? - BeInCrypto
Oil Price Nears Yearly High: Is a Stock and Crypto Crash Coming? BeInCrypto
finance27 minutes ago
Jana Small Finance Bank Q2 FY27 slides: record profit drives guidance upgrade
Jana Small Finance Bank Q2 FY27 slides: record profit drives guidance upgrade....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!